BOIRON June 27, 2019
Press release of June 27, 2019
Due again to a leak in the media, the content of the HAS opinion regarding the upholding of the reimbursement of homeopathic medicines has been made public, even before being communicated to the Laboratoires BOIRON. At the time we are sending this press release, we have still not received notice of this opinion.
This is the reason why a suspension of the trading of the shares has been requested to the AMF today.
Furthermore, this is a new violation of the rules of the evaluation procedure that seriously harms the company, its employees and its shareholders
Laboratoires BOIRON
Our next updates:
July 18, 2019: after the close of the stock market, publication of the sales on June 30, 2019.
Person responsible for financial information: Valérie Lorentz-Poinsot
Contact for financial information: Fabrice Rey
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com
Attachments
- Original document
- Permalink
Disclaimer
Boiron SA published this content on 27 June 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 June 2019 08:09:18 UTC
